Related Experiment Videos

Phosphorylation of the glycoprotein hormone alpha-subunit secreted by human tumor cell lines

Insights

Tumors can produce ectopic proteins from silent genes. This study found that human tumor cells phosphorylate glycoprotein hormone alpha-subunits, a novel modification in both trophoblastic and nontrophoblastic cancers.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Tumors synthesize ectopic proteins via derepression of silent genes.
  • Understanding these ectopic products requires characterizing their physicochemical properties.
  • Comparing ectopic proteins to normal counterparts aids in understanding tumor biology.

Purpose of the Study:

  • To investigate the post-translational modifications of ectopic glycoprotein hormone alpha-subunits in human tumor cell lines.
  • To determine if phosphorylation is a common modification of these ectopic alpha-subunits.
  • To compare modification patterns between trophoblastic and nontrophoblastic tumor-derived cell lines.

Main Methods:

  • Culturing human tumor cell lines (JAR, JEG, HeLa, ChaGo).
  • Analyzing secreted glycoprotein hormone alpha-subunits for phosphorylation.
  • Utilizing biochemical assays to detect covalent modifications.

Main Results:

  • Glycoprotein hormone alpha-subunits secreted by multiple human tumor cell lines are phosphorylated.
  • This phosphorylation occurs in cell lines from both trophoblastic (JAR, JEG) and nontrophoblastic (HeLa, ChaGo) tumors.
  • A choriocarcinoma cell line (JAR) phosphorylates its secreted hCG-alpha subunit but not hCG-beta.

Conclusions:

  • Phosphorylation represents a novel covalent modification of ectopic glycoprotein hormone alpha-subunits in human cancers.
  • This modification is not restricted to trophoblastic tumors, indicating a broader phenomenon in oncogenesis.
  • The selective phosphorylation of the alpha-subunit in choriocarcinoma cells suggests specific regulatory mechanisms.

Related Concept Videos